709 related articles for article (PubMed ID: 34364303)
1. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models.
Wu J; Xu X; Zheng L; Mo J; Jin X; Bao Y
Int Immunopharmacol; 2021 Oct; 99():108025. PubMed ID: 34364303
[TBL] [Abstract][Full Text] [Related]
2. LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease.
Zheng Z; Zhang S; Liu X; Wang X; Xue C; Wu X; Zhang X; Xu X; Liu Z; Yao L; Lu G
J Cell Physiol; 2024 May; 239(5):e31250. PubMed ID: 38477420
[TBL] [Abstract][Full Text] [Related]
3. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.
Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997
[No Abstract] [Full Text] [Related]
4. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
5. DA-9805 protects dopaminergic neurons from endoplasmic reticulum stress and inflammation.
Kang S; Piao Y; Kang YC; Lim S; Pak YK
Biomed Pharmacother; 2022 Jan; 145():112389. PubMed ID: 34775235
[TBL] [Abstract][Full Text] [Related]
6. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
7. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366
[TBL] [Abstract][Full Text] [Related]
8. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
[TBL] [Abstract][Full Text] [Related]
9. α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson's disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway.
Huang B; Hu G; Zong X; Yang S; He D; Gao X; Liu D
Int Immunopharmacol; 2023 Feb; 115():109698. PubMed ID: 36634417
[TBL] [Abstract][Full Text] [Related]
10. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.
Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D
Front Immunol; 2018; 9():2527. PubMed ID: 30455692
[TBL] [Abstract][Full Text] [Related]
11. Kaemperfol alleviates pyroptosis and microglia-mediated neuroinflammation in Parkinson's disease via inhibiting p38MAPK/NF-κB signaling pathway.
Cai M; Zhuang W; Lv E; Liu Z; Wang Y; Zhang W; Fu W
Neurochem Int; 2022 Jan; 152():105221. PubMed ID: 34780806
[TBL] [Abstract][Full Text] [Related]
12. Early glycolytic reprogramming controls microglial inflammatory activation.
Cheng J; Zhang R; Xu Z; Ke Y; Sun R; Yang H; Zhang X; Zhen X; Zheng LT
J Neuroinflammation; 2021 Jun; 18(1):129. PubMed ID: 34107997
[TBL] [Abstract][Full Text] [Related]
13. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
Yan X; Liu DF; Zhang XY; Liu D; Xu SY; Chen GX; Huang BX; Ren WZ; Wang W; Fu SP; Liu JX
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208679
[TBL] [Abstract][Full Text] [Related]
14. HCH6-1, an antagonist of formyl peptide receptor-1, exerts anti-neuroinflammatory and neuroprotective effects in cellular and animal models of Parkinson's disease.
Wang HL; Cheng YC; Yeh TH; Liu HF; Weng YH; Chen RS; Chen YC; Lu JC; Hwang TL; Wei KC; Liu YC; Wang YT; Hsu CC; Chiu TJ; Chiu CC
Biochem Pharmacol; 2023 Jun; 212():115524. PubMed ID: 37001680
[TBL] [Abstract][Full Text] [Related]
15. Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease.
Bao LH; Zhang YN; Zhang JN; Gu L; Yang HM; Huang YY; Xia N; Zhang H
J Neuroinflammation; 2018 May; 15(1):131. PubMed ID: 29720230
[TBL] [Abstract][Full Text] [Related]
16. Biochanin A Protects Against Lipopolysaccharide-Induced Damage of Dopaminergic Neurons Both In Vivo and In Vitro via Inhibition of Microglial Activation.
Wang J; Wu WY; Huang H; Li WZ; Chen HQ; Yin YY
Neurotox Res; 2016 Oct; 30(3):486-98. PubMed ID: 27417698
[TBL] [Abstract][Full Text] [Related]
17. Natural bear bile powder suppresses neuroinflammation in lipopolysaccharide-treated mice via regulating TGR5/AKT/NF-κB signaling pathway.
Zhu H; Wang G; Bai Y; Tao Y; Wang L; Yang L; Wu H; Huang F; Shi H; Wu X
J Ethnopharmacol; 2022 May; 289():115063. PubMed ID: 35149130
[TBL] [Abstract][Full Text] [Related]
18. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602
[TBL] [Abstract][Full Text] [Related]
19. Galectin-1 attenuates neurodegeneration in Parkinson's disease model by modulating microglial MAPK/IκB/NFκB axis through its carbohydrate-recognition domain.
Li Y; Chen N; Wu C; Lu Y; Gao G; Duan C; Yang H; Lu L
Brain Behav Immun; 2020 Jan; 83():214-225. PubMed ID: 31669519
[TBL] [Abstract][Full Text] [Related]
20. Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming.
Gu C; Wang F; Zhang YT; Wei SZ; Liu JY; Sun HY; Wang GH; Liu CF
Aging Cell; 2021 Jun; 20(6):e13375. PubMed ID: 33964119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
